Vinorelbine
Brand name: Navelbine ®
Generic
name:Vinorelbine
Other names: Vinorelbine Tartrate
Therapeutic
Class: plant
alkaloid
Manufacturer /
Distributor: Pierre
Fabre
Availability:
Vinorelbine is
available by prescription only
Indications: Vinorelbine is used to treat many
cancers, mainly:
- non-small
cell lung cancer
- metastatic breast
cancer
- ovarian
cancer
- Hodgkin's
disease.
Vinorelbine can be prescribed for
other medical conditions not listed in this article; contact your doctor or pharmacist for more
information.
Dosage form:
Vinorelbine is given by injection into a vein
Dosage: Your oncologist will consider several
criteria to prescribe your an appropriate dosage: your age, body surface area (height and weight), type of
cancer treated, taking other medications or not, as well as your health status. Usually, a lower dose of
Vinorelbine is recommended when it is taken in combination with other drugs or therapy (radiotherapy for
instance). Depending on your body’s reaction to the drug, your
doctor may stop or change the way you take it.
Usually,
Vinorelbine is injected into a vein. Vinorelbine can be used alone or in combination with other chemotherapy
medications. The usual dose is 25-30 mg/m2 body surface, once a week. To avoid endovenous irritation, your
doctor may dilute the drug in normal saline, and infuse it in 20 minutes, following by a rinsing of the vein. In
general, the drug is given in a hospital or health center with sterilization equipment for its preparation.
Vinorelbine should be administered by your oncologist or a physician experienced in chemotherapy
drugs.
Overdose: overdosing any chemotherapy drug is
dangerous. Overdose of Vinorelbine can lead to a decrease in white
blood cells and platelets, which can cause serious infections. Even in the absence of overdose, Vinorelbine can
cause neurological problems, which can be characterized by an abolition of tendon reflexes and impaired
sensitivity to the limbs. Vinorelbine can also cause broncho-pulmonary and heart problems.
During
the treatment, keep all appointments with your doctor and laboratory. Contact your doctor or the poison control
center nearest you immediately if you experience these symptoms: loss of muscle coordination, vision and/or
speech problems, sore throat, persistent cough, frequent or painful urination.
Missing dose:
Vinorelbine
is given in hospital; it is basically difficult for you to miss any dose if you are present in the hospital for the
treatment. Therefore, it is very important to keep all appointments with your
doctor
. If for some reasons you cannot go to the hospital, contact your oncologist before the date scheduled for the
therapy. Do not stay home because you experience adverse
effects; Vinorelbine
causes side effects in most patients.
Contraindication: Vinorelbine is contraindicated or should be used with
precaution in the following conditions:
- allergic
to Vinorelbine
or any of its ingredients
- low
white blood cell count and/or platelets
- Women
who are pregnant or breastfeeding.
Mechanism of action (MOA): Vinorelbine belongs to the plant alkaloids; it slows or stops the progression
of cancer cells by interfering with their genetic material (DNA), an element essential for their reproduction.
Interactions: talk you to your doctor before taking
aspirin, vitamins, nutritional supplements, or any non prescription medication. Certain medications can interact
with Vinorelbine. Tell your doctor or pharmacist if you are taking any prescription medication, especially
cisplatin (Platinol), mitomycin (Mutamycin), and other chemotherapeutic drugs.
Side
effects:
as with any chemotherapy drugs, Vinorelbine cause
side effects in most patients. Most common Vinorelbine side effects
include
:
- fatigue
- nausea
- vomitting
- diarrhea
- constipation
- hair loss
- increased risk of infections
- Numbness
or tingling in hands or feet.
If the side
effects above persist for weeks, contact your oncologist. In addition, contact your doctor immediately if you
experience any of these symptoms:
- fever
- chills
- shortness
of breath
- persistent
cough
- severe
constipation
- persistent
diarrhea
- abnormal
burning and tingling
- unusual
bleeding or bruising
- sore throat or mouth
pain
- Redness,
pain, or swelling at the site of the injection.
References:
|